Discontinued — last reported Q4 '25
Teradyne, Inc. Interest Paid remained flat by 0.0% to $791.00K in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 312.5%, from $191.75K to $791.00K. Over 4 years (FY 2021 to FY 2025), Interest Paid shows a downward trend with a -7.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
cf_interest_paid| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $4.24M | $1.50M | $296.00K | $767.00K | $3.16M |
| YoY Change | — | -64.6% | -80.2% | +159.1% | +312.5% |